Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 26, 2016 ) DelveInsight's, "Neuropilin 1 (NP-1) Receptor Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Neuropilin 1 (NP-1) Receptor Antagonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Neuropilin 1 (NP-1) Receptor Antagonists. DelveInsight's Report also assesses the Neuropilin 1 (NP-1) Receptor Antagonists therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. For more information about this report: http://www.reportsweb.com/neuropilin-1-np-1-receptor-antagonists-pipeline-insights-2016
Table of Contents - Neuropilin 1 (NP-1) Receptor Antagonists Overview - Neuropilin 1 (NP-1) Receptor Antagonists Disease Associated - Neuropilin 1 (NP-1) Receptor Antagonists Pipeline Therapeutics - Neuropilin 1 (NP-1) Receptor Antagonists Therapeutics under Development by Companies - Neuropilin 1 (NP-1) Receptor Antagonists Filed and Phase III Products - Comparative Analysis - Neuropilin 1 (NP-1) Receptor Antagonists Phase II Products - Comparative Analysis - Neuropilin 1 (NP-1) Receptor Antagonists Phase I and IND Filed Products
Request Sample Copy at http://www.reportsweb.com/inquiry&RW000184555/sample
- Comparative Analysis - Neuropilin 1 (NP-1) Receptor Antagonists Discovery and Pre-Clinical Stage Products - Comparative Analysis - Drug Candidate Profiles - Neuropilin 1 (NP-1) Receptor Antagonists - Therapeutics Assessment - Assessment by Monotherapy Products - Assessment by Combination Products - Assessment by Route of Administration - Assessment by Molecule Type - Neuropilin 1 (NP-1) Receptor Antagonists - Discontinued Products - Neuropilin 1 (NP-1) Receptor Antagonists - Dormant Products - Companies Involved in Therapeutics Development for Neuropilin 1 (NP-1) Receptor Antagonists
Inquire before Buying at http://www.reportsweb.com/inquiry&RW000184555/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|